These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 33369268)

  • 1. Natural history of Type 2 and 3 spinal muscular atrophy: 2-year NatHis-SMA study.
    Annoussamy M; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Laugel V; Schara U; Gidaro T; Lilien C; Hogrel JY; Carlier P; Fournier E; Lowes L; Gorni K; Ly-Le Moal M; Hellbach N; Seabrook T; Czech C; Hermosilla R; Servais L;
    Ann Clin Transl Neurol; 2021 Feb; 8(2):359-373. PubMed ID: 33369268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
    Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
    Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes.
    Sivo S; Mazzone E; Antonaci L; De Sanctis R; Fanelli L; Palermo C; Montes J; Pane M; Mercuri E
    Neuromuscul Disord; 2015 Mar; 25(3):212-5. PubMed ID: 25500010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing upper limb function in nonambulant SMA patients: development of a new module.
    Mazzone E; Bianco F; Martinelli D; Glanzman AM; Messina S; De Sanctis R; Main M; Eagle M; Florence J; Krosschell K; Vasco G; Pelliccioni M; Lombardo M; Pane M; Finkel R; Muntoni F; Bertini E; Mercuri E
    Neuromuscul Disord; 2011 Jun; 21(6):406-12. PubMed ID: 21421316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Annoussamy M; Mayer M; Maincent K; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(4):e0121799. PubMed ID: 25861036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes.
    Coratti G; Carmela Pera M; Montes J; Scoto M; Pasternak A; Bovis F; Sframeli M; D'Amico A; Pane M; Albamonte E; Antonaci L; Lia Frongia A; Mizzoni I; Sansone VA; Russo M; Bruno C; Baranello G; Messina S; Dunaway Young S; Glanzman AM; Duong T; de Sanctis R; Stacy Mazzone E; Milev E; Rohwer A; Civitello M; Darras BT; Bertini E; Day J; Muntoni F; De Vivo DC; Finkel RS; Mercuri E
    Neuromuscul Disord; 2022 Jan; 32(1):36-42. PubMed ID: 34980538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial.
    Seferian AM; Moraux A; Annoussamy M; Canal A; Decostre V; Diebate O; Le Moing AG; Gidaro T; Deconinck N; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Maincent K; Desguerre I; Thémar-Noël C; Cuisset JM; Tiffreau V; Denis S; Jousten V; Quijano-Roy S; Voit T; Hogrel JY; Servais L
    PLoS One; 2015; 10(2):e0113999. PubMed ID: 25643053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy.
    Bendixen RM; Butrum J; Jain MS; Parks R; Hodsdon B; Nichols C; Hsia M; Nelson L; Keller KC; McGuire M; Elliott JS; Linton MM; Arveson IC; Tounkara F; Vasavada R; Harnett E; Punjabi M; Donkervoort S; Dastgir J; Leach ME; Rutkowski A; Waite M; Collins J; Bönnemann CG; Meilleur KG
    Neuromuscul Disord; 2017 Mar; 27(3):278-285. PubMed ID: 28087121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients.
    Servais L; Deconinck N; Moraux A; Benali M; Canal A; Van Parys F; Vereecke W; Wittevrongel S; Mayer M; Desguerre I; Maincent K; Themar-Noel C; Quijano-Roy S; Serari N; Voit T; Hogrel JY
    Neuromuscul Disord; 2013 Feb; 23(2):139-48. PubMed ID: 23219352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study.
    Veldhoen ES; Wijngaarde CA; Hulzebos EHJ; Wösten-van Asperen RM; Wadman RI; van Eijk RPA; Asselman FL; Stam M; Otto LAM; Cuppen I; Scheijmans FEV; den Oudenrijn LPV; Bartels B; Gaytant MA; van der Ent CK; van der Pol WL
    Orphanet J Rare Dis; 2022 Feb; 17(1):70. PubMed ID: 35189949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
    Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
    Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Hand Strength and Function in Duchenne Muscular Dystrophy and Spinal Muscular Atrophy: Implications for Clinical Trials.
    Decostre V; De Antonio M; Servais L; Hogrel JY
    J Neuromuscul Dis; 2024; 11(4):777-790. PubMed ID: 38788084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative description of upper extremity function and activity of people with spinal muscular atrophy.
    Janssen MMHP; Peeters LHC; de Groot IJM
    J Neuroeng Rehabil; 2020 Sep; 17(1):126. PubMed ID: 32917233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.
    Chabanon A; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Cuisset JM; Laugel V; Schara U; Gidaro T; Gilabert S; Hogrel JY; Baudin PY; Carlier P; Fournier E; Lowes LP; Hellbach N; Seabrook T; Toledano E; Annoussamy M; Servais L;
    PLoS One; 2018; 13(7):e0201004. PubMed ID: 30048507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot study.
    Otto LAM; Froeling M; van Eijk RPA; Asselman FL; Wadman R; Cuppen I; Hendrikse J; van der Pol WL
    NMR Biomed; 2021 Apr; 34(4):e4473. PubMed ID: 33480130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3.
    Khirani S; Colella M; Caldarelli V; Aubertin G; Boulé M; Forin V; Ramirez A; Fauroux B
    Eur J Paediatr Neurol; 2013 Nov; 17(6):552-60. PubMed ID: 23672834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.